Simplification of T Cell Manufacturing Using the G-Rex Platform as First Step Towards Automation
This pre-recorded webinar presentation features Anastasiya Smith, Senior Director of R&D of Marker Therapeutics outlines the following in achieving automation through the first step of simplification for cell therapy programs.
–Process Automation: In-house process development to simplify and prepare for automation
–Reagent Standardization: Standardization of reagents to enable process automation
–Process Automation: Implementation of robotics to automate the simplified process
To view the 15-minute webinar, fill out the form below for instant access.
Join Anastasiya Smith, Snr. Director of R&D at Marker Therapeutics for a 15-minute pre-recorded webinar covering the first critical steps in successful automation through simplification with the G-Rex platform.